Teva Pharmaceutical Industries shares owned by Capital Research and Management Company - Division 3
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Capital Research and Management Company - Division 3
from 13F filings
Historical chart of Capital Research and Management Company - Division 3 investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Capital Research and Management Company - Division 3 consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Teva Pharmaceutical Industries by Capital Research and Management Company - Division 3
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $55M | 2.7M | 20.20 |
| 2025-06-30 | $45M | 2.7M | 16.76 |
| 2025-03-31 | $42M | 2.7M | 15.37 |
| 2024-12-31 | $59M | 2.7M | 22.04 |
| 2024-09-30 | $57M | 3.2M | 18.02 |
| 2024-03-31 | $45M | 3.2M | 14.11 |
| 2023-12-31 | $104M | 10M | 10.44 |
| 2023-09-30 | $102M | 10M | 10.20 |
| 2023-06-30 | $75M | 10M | 7.53 |
| 2023-03-31 | $88M | 10M | 8.85 |
| 2022-12-31 | $97M | 11M | 9.12 |
| 2022-03-31 | $94M | 10M | 9.39 |
| 2021-12-31 | $80M | 10M | 8.01 |
| 2021-09-30 | $97M | 10M | 9.74 |
| 2021-06-30 | $99M | 10M | 9.90 |
| 2021-03-31 | $169M | 15M | 11.54 |
| 2020-12-31 | $256M | 27M | 9.65 |
| 2020-09-30 | $211M | 23M | 9.01 |
| 2020-06-30 | $253M | 21M | 12.33 |
| 2020-03-31 | $125M | 14M | 8.98 |
| 2017-03-31 | $23M | 712k | 32.09 |
| 2016-12-31 | $26M | 712k | 36.25 |
| 2016-09-30 | $33M | 712k | 46.01 |
| 2016-06-30 | $36M | 710k | 50.23 |
| 2016-03-31 | $38M | 710k | 53.51 |
| 2015-12-31 | $47M | 710k | 65.64 |
| 2015-09-30 | $40M | 710k | 56.46 |
| 2015-06-30 | $42M | 710k | 59.10 |
| 2015-03-31 | $44M | 710k | 62.30 |
| 2014-12-31 | $41M | 710k | 57.51 |
| 2014-09-30 | $38M | 710k | 53.75 |
| 2014-06-30 | $37M | 710k | 52.42 |
| 2014-03-31 | $38M | 710k | 52.84 |
| 2013-12-31 | $29M | 710k | 40.08 |
| 2013-09-30 | $27M | 710k | 37.78 |
| 2013-06-30 | $28M | 710k | 39.20 |
More positions owned by Capital Research and Management Company - Division 3
View all positions for Capital Research and Management Company - Division 3
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries